Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis
- PMID: 20229499
- DOI: 10.1002/cyto.a.20887
Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis
Abstract
Although target cell cytolysis has been widely employed to describe effector function of cells, cytolysis assays as commonly employed do not generate quantitative data. In this report we describe the development and application of a statistically supported flow cytometry-based assay to quantify cell-mediated cytolysis. The assay depends on the use of the fluorescent dye CFSE to distinguish target from effector cells, the DNA intercalating dye 7AAD to distinguish dead from live cell events, and on the establishment of a cytolysis curve that allows for the derivation of statistically robust data. We demonstrate that the cytolysis curve is well described by a four parameter logistic regression model provided that (i) the range of effector to target (E:T) ratios studied allows for full description of the logistic curve, and (ii) an adequate number of data points are collected to estimate the model parameters. We show that the assay is highly reproducible and accurate, and comparable in sensitivity with the standard (51)Cr assay. We report on the potential for this assay to generate quantitative data on the cytolytic activity of both CD8 T and NK cells; describe a relationship between the efficiency of effector cell degranulation and target cell cytolysis throughout a range of E:T ratios, and demonstrate the potential to multiplex with other platforms to obtain broader datasets for the effector phenotype of cells. Appropriate use of this assay will enhance the ability to derive quantitative and integrated correlative datasets from basic, translational, and clinical studies.
Copyright 2010 International Society for Advancement of Cytometry.
Similar articles
-
An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.Ann Clin Lab Sci. 2012 Winter;42(1):42-9. Ann Clin Lab Sci. 2012. PMID: 22371909
-
Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays.Immunobiology. 2008;213(8):629-40. doi: 10.1016/j.imbio.2008.02.006. Epub 2008 Apr 28. Immunobiology. 2008. PMID: 18765168
-
A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.J Immunol Methods. 2007 Aug 31;325(1-2):140-7. doi: 10.1016/j.jim.2007.06.013. Epub 2007 Jul 16. J Immunol Methods. 2007. PMID: 17663991
-
Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometry.J Lipid Mediat Cell Signal. 1994 Feb;9(1):19-25. J Lipid Mediat Cell Signal. 1994. PMID: 8032712 Review.
-
Deriving Quantitative Cell Biological Information from Dye-Dilution Lymphocyte Proliferation Experiments.Methods Mol Biol. 2018;1707:81-94. doi: 10.1007/978-1-4939-7474-0_6. Methods Mol Biol. 2018. PMID: 29388101 Free PMC article. Review.
Cited by
-
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.Sci Transl Med. 2012 May 16;4(134):134ra62. doi: 10.1126/scitranslmed.3003330. Sci Transl Med. 2012. PMID: 22593175 Free PMC article. Clinical Trial.
-
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.Blood. 2014 Apr 10;123(15):2343-54. doi: 10.1182/blood-2013-09-529537. Epub 2014 Mar 4. Blood. 2014. PMID: 24596416 Free PMC article.
-
An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.PLoS One. 2019 Jan 9;14(1):e0210540. doi: 10.1371/journal.pone.0210540. eCollection 2019. PLoS One. 2019. PMID: 30625227 Free PMC article.
-
CD38 as a pan-hematologic target for chimeric antigen receptor T cells.Blood Adv. 2023 Aug 22;7(16):4418-4430. doi: 10.1182/bloodadvances.2022007059. Blood Adv. 2023. PMID: 37171449 Free PMC article.
-
Genetic defects in cytolysis in macrophage activation syndrome.Curr Rheumatol Rep. 2014;16(9):439. doi: 10.1007/s11926-014-0439-2. Curr Rheumatol Rep. 2014. PMID: 25086802 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials